EUFEPS QbD-PAT Sciences Network new Position Paper

The regulatory and technical landscape of the pharmaceutical field is rapidly evolving from one focused predominantly on development of small molecules, using well established manufacturing technologies towards an environment in which biologicals and complex modalities are being developed using advanced science and technology coupled with the application of modern Quality by Design (QbD)...

Equivalence of Complex Drug Products: Scientific and Regulatory Challenges

This convening, on November 9, 2016, in New York, USA, is co-sponsored by EUFEPS and aims to identify the best approaches for complex drug development and regulation, to outline outstanding challenges in the assessment of complex drug equivalence and consequences for interchangeability of products, to address whether the regulatory approaches for biosimilars should be used as models for other...

7th BBBB International Conference on Pharmaceutical Sciences

This conference will be held on October 5-7, 2017, Balatonfüred, Hungary, and the series initiated by EUFEPS started in 2005 for close cooperation among the Pharmaceutical Societies of Hungary, Finland, Estonia, Slovenia, and the Turkish Pharmaceutical Technology Scientists’ Association, i.e. member organisations of EUFEPS. It gathers members of these organisations and colleagues from...

Position Paper on Veterinary Medicines – New EUFEPS Network Initiative

Veterinary medicines account for a substantial portion of the production, sale, and consumption of medicines in Europe, and probably world-wide. This calls our attention to the fact that only healthy farm animals can ensure safe and sufficient livestock products to meet the growing demand for animal protein. Human and veterinary medicine share many common features - expressed and symbolised by...